Medigus Ltd. WT C EXP 072323

Medigus Ltd. WT C EXP 072323

MDGSW
Medigus Ltd. WT C EXP 072323US flagNASDAQ Capital Market
0.02
USD
+0.00
- -
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChat
CEO
None
Sector
Healthcare
Industry
Medical - Devices
Address
United States of America
IPO Date
Jul 23, 2018
Business
Xylo Technologies Ltd., formerly Medigus Ltd., operates as a technology holding company focused on innovative growth partnerships in advanced medical solutions, digital commerce, and electric vehicle markets; it maintains affiliations with portfolio companies including Polyrizon Ltd. for medical solutions, Gix Internet Ltd., Jeffs' Brands, and Eventer Technologies Ltd. for online advertising, e-commerce, event management, and internet traffic routing; and Charging Robotics Ltd., Revoltz Ltd., and ParaZero Technologies Ltd. for electric vehicle wireless charging, battery technologies, and drone safety systems. The company, founded in 1999 and headquartered in Tel Aviv, Israel, with prior operations based in Omer, also develops miniaturized imaging equipment via legacy ScoutCam technologies, biological gels for allergen protection, and the Medigus Ultrasonic Surgical Endostapler (MUSE system) endoscopy platform for gastroesophageal reflux disease treatment, alongside real estate and electronics segments; it generates revenue primarily from the United States, Europe, and Asia. In April 2024, Medigus rebranded to Xylo Technologies Ltd. to reflect its expanded technology portfolio and growth strategy; recently, it signed a letter of intent to acquire 51% of a German AI predictive maintenance company for 1.5 million Euros down payment plus performance-based earnout, broadening into AI for aerospace, aviation, and transportation; subsidiary Revoltz secured Israeli regulatory approval for its Porto EV micro-charging stations in February 2025; and in November 2025, it agreed to sell MUSE system patents and IP to SciSparc Ltd. for shares representing 19.99% of SciSparc's capital, replicating prior Greater China licensing models globally.